Santhera Announces Successful Outcome of Phase III Study with Catena®/Raxone® in Duchenne Muscular Dystrophy Santhera Pharmaceuticals, 13 May 2014 Accessed on 17 May 2014 from http://www.santhera.com/index.php?docid=212&vid=&lang=en&newsdate=201405&newsid=1784768&newslang=en. CommentRecommendBookmarkWatch